Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 11 studies | 33% ± 11% | |
| oligodendrocyte precursor cell | 10 studies | 28% ± 12% | |
| astrocyte | 7 studies | 27% ± 11% | |
| GABAergic neuron | 4 studies | 21% ± 6% | |
| interneuron | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 8 studies | 23% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 223.98 | 2576 / 2642 | 97% | 7.17 | 684 / 705 |
| esophagus | 65% | 108.51 | 944 / 1445 | 61% | 2.52 | 112 / 183 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.67 | 1 / 1 |
| skin | 51% | 36.60 | 917 / 1809 | 30% | 0.98 | 143 / 472 |
| intestine | 64% | 44.21 | 618 / 966 | 15% | 0.45 | 78 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 67% | 1.37 | 30 / 45 |
| bladder | 38% | 19.76 | 8 / 21 | 25% | 0.84 | 126 / 504 |
| ovary | 31% | 18.97 | 56 / 180 | 31% | 0.90 | 135 / 430 |
| lung | 25% | 11.07 | 144 / 578 | 37% | 1.32 | 422 / 1155 |
| breast | 23% | 13.59 | 107 / 459 | 31% | 0.98 | 348 / 1118 |
| uterus | 32% | 19.61 | 55 / 170 | 22% | 0.72 | 99 / 459 |
| prostate | 44% | 27.15 | 109 / 245 | 6% | 0.16 | 30 / 502 |
| thymus | 40% | 22.56 | 264 / 653 | 9% | 0.19 | 57 / 605 |
| stomach | 23% | 11.77 | 84 / 359 | 19% | 0.64 | 54 / 286 |
| blood vessel | 41% | 25.21 | 550 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 38% | 16.55 | 307 / 803 | 0% | 0 | 0 / 0 |
| adipose | 37% | 18.62 | 440 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 36% | 15.63 | 86 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 19% | 7.43 | 48 / 258 | 10% | 0.23 | 24 / 230 |
| pancreas | 20% | 11.42 | 66 / 328 | 6% | 0.14 | 11 / 178 |
| liver | 6% | 1.82 | 13 / 226 | 17% | 0.35 | 71 / 406 |
| kidney | 18% | 8.07 | 16 / 89 | 4% | 0.08 | 39 / 901 |
| heart | 14% | 6.32 | 120 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.26 | 3 / 29 |
| peripheral blood | 10% | 14.26 | 95 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0000209 | Biological process | protein polyubiquitination |
| GO_1990904 | Cellular component | ribonucleoprotein complex |
| GO_0061630 | Molecular function | ubiquitin protein ligase activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | MKRN3 |
| Protein name | Makorin ring finger protein 3 Probable E3 ubiquitin-protein ligase makorin-3 (EC 2.3.2.27) (RING finger protein 63) (RING-type E3 ubiquitin transferase makorin-3) (Zinc finger protein 127) MKRN3 protein (Makorin ring finger protein 3) |
| Synonyms | RNF63 D15S9 ZNF127 |
| Description | FUNCTION: E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. . |
| Accessions | Q13064 A0A3B3IRN4 A0A7I2V2Q0 A0A3B3ISD8 ENST00000568252.1 ENST00000564592.2 A0A7I2YQ72 ENST00000677119.1 ENST00000647595.1 ENST00000314520.6 H3BPL3 ENST00000649065.1 A0A7I2V2S4 ENST00000677372.1 ENST00000676568.1 Q6NSB6 A0A7I2V6H1 ENST00000679144.1 ENST00000678440.1 A0A3B3IRU9 A0A7I2V4D6 ENST00000568945.2 |
